Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
暂无分享，去创建一个
J. Hogan | A. Servais | E. Rondeau | F. Provôt | V. Frémeaux-Bacchi | A. Karras | F. Fakhouri | C. Loirat | C. Rafat | C. Barbet | M. Cailliez | Y. Delmas | J. Coindre | V. Châtelet | M. Fila | R. Makdassi | F. Louillet